Among listed pharmaceutical companies, the ratio of R&D investment to sales was 7.6% on average
According to the 2014 business report of listed pharmaceutical companies settled in Dec which is submitted to Financial Supervisory Service, the ratio of R&D investment to sales was 7.6% on average.
The ratio was 7.2% in 2011, and 7.4% in 2012. Pharmaceutical companies are continuing to increase...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
